Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Yum China | YUMC | Sep 20, 2024 | 35.53 | +0.28 |
Yum! Brands | YUM | Sep 20, 2024 | 129.71 | -1.05 |
Yunhong Green CTI | YHGJ | Sep 20, 2024 | 1.01 | +1.01 |
Yunji ADR | YJ | Sep 20, 2024 | 2.21 | -0.45 |
YXT.COM Group Holding | YXT | Sep 20, 2024 | 4.11 | 0.00 |
YY Group Holding | YYGH | Sep 20, 2024 | 0.92 | +2.25 |
Zai Lab ADR | ZLAB | Sep 20, 2024 | 21.85 | +3.60 |
Zalatoris II Acquisition | ZLS | Sep 20, 2024 | 11.06 | 0.00 |
Zapata Computing | ZPTA | Sep 20, 2024 | 0.38 | -3.23 |
Zapp Electric Vehicles Group | ZAPP | Sep 20, 2024 | 2.96 | -6.92 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Sep 20, 2024 | 48.03 | +0.36 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Sep 20, 2024 | 66.96 | +0.41 |
Zebra Technologies A | ZBRA | Sep 20, 2024 | 366.76 | +0.82 |
Zedge B | ZDGE | Sep 20, 2024 | 3.18 | +2.58 |
ZEEKR Intelligent Technology Holding | ZK | Sep 20, 2024 | 16.21 | -1.46 |
Zentalis Pharmaceuticals | ZNTL | Sep 20, 2024 | 4.22 | -3.21 |
Zentek | ZTEK | Sep 20, 2024 | 0.76 | +1.33 |
Zenvia A | ZENV | Sep 20, 2024 | 1.50 | 0.00 |
Zeo Energy A | ZEO | Sep 20, 2024 | 2.79 | +7.31 |
Zepp Health ADR | ZEPP | Sep 20, 2024 | 3.30 | +1.23 |
Zeta Global A | ZETA | Sep 20, 2024 | 28.94 | +1.90 |
Zevia A | ZVIA | Sep 20, 2024 | 1.19 | 0.00 |
Zevra Therapeutics | ZVRA | Sep 20, 2024 | 8.06 | +0.50 |
Zhibao Technology | ZBAO | Sep 20, 2024 | 3.98 | +1.53 |
Zhihu A ADR | ZH | Sep 20, 2024 | 3.24 | -0.31 |
Zhongchao A | ZCMD | Sep 20, 2024 | 1.25 | -2.65 |
Ziff Davis | ZD | Sep 20, 2024 | 50.99 | -3.72 |
Zillow Group A | ZG | Sep 20, 2024 | 65.05 | -1.12 |
Zillow Group C Capital Stock | Z | Sep 20, 2024 | 67.09 | -1.11 |
ZIM | ZIM | Sep 20, 2024 | 20.06 | -1.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.